Mgr. Michal Šmída, Dr. rer. nat.

2022

• CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation.

  DOSTÁLOVÁ Lenka LEDEREROVÁ Aneta PESCHELOVÁ Helena HEJRET Václav ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML

  LODHI Yusuf LADUNGOVÁ Adriana BUŠA Daniel PESCHELOVÁ Helena ČULEN Martin ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Chasing the epigenetic landscape to enhance CAR-T cell activity by preventing CD19 antigen escape in relapsed models.

  GOTTUMUKKALA Narendra Varma MANČÍKOVÁ Veronika LEDEREROVÁ Aneta KOZLOVÁ Veronika DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana LODHI Yusuf VERNER Jan ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells

  DAVE Zankruti VONDÁLOVÁ BLANÁŘOVÁ Olga ČADA Štěpán JANOVSKÁ Pavlína ZEZULA Nikodém BĚHAL Martin HANÁKOVÁ Kateřina GANJI Sri Ranjani KREJČÍ Pavel GÖMÖRYOVÁ Kristína PESCHELOVÁ Helena ŠMÍDA Michal ZDRÁHAL Zbyněk PAVLOVÁ Šárka KOTAŠKOVÁ Jana POSPÍŠILOVÁ Šárka BRYJA Vítězslav

  Article in Periodical

  Frontiers in Cell and Developmental Biology, year: 2022, volume: 10, edition: February 2022, DOI

• Prediction of novel treatment options for CLL and AML cells based on drug repurposing.

  LADUNGOVÁ Adriana BUŠA Daniel PESCHELOVÁ Helena LODHI Yusuf ČULEN Martin ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing.

  LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• The use of functional genomics for advancing monoclonal antibody therapy of chronic lymphocytic leukemia

  ŠMÍDA Michal

  Year: 2022, type:

2021

• CD19 hypermethylation as an escape to CART-19.

  ŠMÍDA Michal

  Conference abstract

  Year: 2021, type: Conference abstract

• CD19 promoter hypermethylation as means of antigen-negative escape to CART-19 therapy.

  DOSTÁLOVÁ Lenka LEDEREROVÁ Aneta KOZLOVÁ Veronika PESCHELOVÁ Helena LADUNGOVÁ Adriana MANČÍKOVÁ Veronika ŠMÍDA Michal

  Conference abstract

  Year: 2021, type: Conference abstract

• CD19 promotor hypermethylation results in CD19 antigen-negative relapse to CAR-T cells.

  ŠMÍDA Michal

  Year: 2021, type: